The U.S. government has introduced a revised framework for global health funding, abandoning open-ended aid in favor of five-year bilateral agreements. Under the America First Global Health Strategy, unveiled in September 2025, the administration has formalized Memorandums of Understanding (MOUs) with 36 countries, covering the period from 2026 through 2030. These agreements require partner nations to increase their own health spending as U.S. contributions decline over time.
This approach differs sharply from previous models, which provided funding without tying it to domestic investment. The new strategy demands that recipient countries demonstrate they can sustain health programs independently. Implementation began in late 2025, with the first agreements now active.
Data from October 2026 reveals the financial impact of this shift. Across the 36 nations with signed MOUs, total U.S. funding over five years will decrease by $8.1 billion, a reduction of 34% compared to earlier levels. Some agreements, including those with Bolivia, Botswana, Panama, and South Sudan, span only three years, further limiting long-term U.S. commitments.
The policy reflects a broader emphasis on country ownership, meaning health systems should rely less on external support. Vietnam’s MOU, for instance, includes a commitment to raise its annual health spending from $23.3 billion to $33.8 billion by 2030, though the exact co-financing requirements remain unspecified in public documents.
Not all agreements follow identical structures. The Philippines signed a Strategic Objective Agreement instead of a full MOU, leaving some financial details unclear. Meanwhile, Malawi’s co-investment terms were outlined in a State Department press release rather than the formal agreement text.
New rules demand measurable health progress
The U.S. has not detailed how it will enforce these commitments or address failures to comply.
Read Also: Medicaid overhaul shifts burden onto states with expansion programs
One key change is greater accountability. Past aid programs often distributed funds without strict conditions, but the MOUs now require measurable progress. For example, agreements explicitly reference global health security (GHS), linking U.S. support to outbreak preparedness and threat response. Countries must now justify how their increased budgets align with these priorities.
However, the transition has created challenges. In Botswana and South Sudan, prior funding comparisons are limited to planned allocations for fiscal years 2023–2025, obscuring the full impact of the cuts. For Bolivia and Panama, data gaps prevent even basic before-and-after comparisons.
The new approach also introduces uneven timelines. While most MOUs cover five years, the shorter agreements in four countries disrupt long-term planning. Health programs dependent on steady funding may face instability if a three-year deal expires before renewal negotiations begin.
Uncertainty looms over compliance and funding gaps
So far, the focus has remained on signing agreements. The next critical phase—ensuring partner countries honor their commitments—will determine whether the strategy strengthens health systems or merely shifts financial responsibility without improving outcomes.
Information for tracking these agreements comes from public statements by the State Department, U.S. embassies, and health ministries in partner nations. When full MOUs are available, analysts extract annual funding figures directly from the documents. In Malawi’s case, details rely on a State Department release rather than a signed text.
Historical funding totals are based on U.S. appropriations and planned amounts for fiscal years 2021–2023, plus requested figures for 2024–2025 under the Global Health Programs account. These numbers reflect only American contributions, excluding any partner investments. Comparisons between past and proposed levels therefore focus solely on U.S. funding.
